Biggest News Aggregation in the World
📰 Nasdaq Edit News

Page 7 - Nasdaq Edit News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Nasdaq Edit. Real-time updates on events, politics, business and more.

Zacks: Analysts Expect Editas Medicine, Inc. (NASDAQ:EDIT) Will Announce Earnings of -$0.84 Per Share

Brokerages predict that Editas Medicine, Inc. (NASDAQ:EDIT – Get Rating) will post earnings of ($0.84) per share for the current fiscal quarter, Zacks Investment Research reports. Five analysts have issued estimates for Editas Medicine’s earnings. The lowest EPS estimate is ($0.93) and the highest is ($0.72). Editas Medicine posted earnings of ($0.81) per share in […]
Robertw Baird Financial Group Zacks Investment Research Editas Medicine Inc Covestor Ltd Ahrens Investment Partners

Brokerages Expect Editas Medicine, Inc. (NASDAQ:EDIT) to Post -$0.81 EPS

Analysts expect that Editas Medicine, Inc. (NASDAQ:EDIT – Get Rating) will post earnings of ($0.81) per share for the current quarter, according to Zacks. Four analysts have provided estimates for Editas Medicine’s earnings. The lowest EPS estimate is ($0.91) and the highest is ($0.75). Editas Medicine reported earnings of ($0.86) per share during the same […]
Robertw Baird Geode Capital Management Zacks Investment Research Jpmorgan Chase Co Editas Medicine Inc Victory Capital Management Inc

Zacks: Analysts Anticipate Editas Medicine, Inc. (NASDAQ:EDIT) Will Post Quarterly Sales of $4.60 Million

Wall Street analysts expect Editas Medicine, Inc. (NASDAQ:EDIT – Get Rating) to report $4.60 million in sales for the current quarter, according to Zacks. Three analysts have issued estimates for Editas Medicine’s earnings. The highest sales estimate is $5.00 million and the lowest is $3.80 million. Editas Medicine reported sales of $6.50 million in the […]
United States Michelle Robertson Securities Exchange Commission Zacks Investment Research Thrivent Financial For Lutherans Norges Bank

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Bruce Eaton Sells 1,258 Shares of Editas Medicine, Inc. (NASDAQ:EDIT) Stock

Editas Medicine, Inc. (NASDAQ:EDIT – Get Rating) EVP Bruce Eaton sold 1,258 shares of the company’s stock in a transaction dated Friday, April 1st. The shares were sold at an average price of $19.64, for a total transaction of $24,707.12. The transaction was disclosed in a legal filing with the SEC, which is accessible through […]
United States Bruce Eaton Zacks Investment Research Thrivent Financial For Lutherans Norges Bank Vienna Asset Management

Editas Medicine, Inc. (NASDAQ:EDIT) Receives Average Rating of "Hold" from Brokerages

Editas Medicine, Inc. (NASDAQ:EDIT – Get Rating) has earned a consensus recommendation of “Hold” from the thirteen research firms that are covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell rating, four have given a hold rating and six have given a buy rating to the company. The average 12-month […]
Michelle Robertson Feng Zhang Jennifera Doudna Lord Abbett Zacks Investment Research Norges Bank

Editas Medicine, Inc. (NASDAQ:EDIT) Shares Purchased by Cetera Advisor Networks LLC

Cetera Advisor Networks LLC boosted its position in Editas Medicine, Inc. (NASDAQ:EDIT – Get Rating) by 8.4% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 8,667 shares of the company’s stock after purchasing an additional 671 shares during the period. Cetera Advisor Networks […]
Michelle Robertson Thomson Reuter Feng Zhang Jennifera Doudna Securities Exchange Commission Zacks Investment Research

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science